199 related articles for article (PubMed ID: 19075881)
1. Recent developments and patenting of lipoprotein based formulations.
Lackó AG; Stewart DR; McClain R; Prókai L; McConathy WJ
Recent Pat Drug Deliv Formul; 2007; 1(2):143-5. PubMed ID: 19075881
[TBL] [Abstract][Full Text] [Related]
2. Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs.
Lacko AG; Nair M; Prokai L; McConathy WJ
Expert Opin Drug Deliv; 2007 Nov; 4(6):665-75. PubMed ID: 17970668
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery via lipoprotein-based carriers: answering the challenges in systemic therapeutics.
Sabnis N; Lacko AG
Ther Deliv; 2012 May; 3(5):599-608. PubMed ID: 22834404
[TBL] [Abstract][Full Text] [Related]
4. Lipoproteins for therapeutic delivery: recent advances and future opportunities.
Raut S; Dasseux JL; Sabnis NA; Mooberry L; Lacko A
Ther Deliv; 2018 Mar; 9(4):257-268. PubMed ID: 29495929
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in drug delivery: potential and limitations of carbon nanotubes.
Prakash S; Kulamarva AG
Recent Pat Drug Deliv Formul; 2007; 1(3):214-21. PubMed ID: 19075888
[TBL] [Abstract][Full Text] [Related]
6. [Recent development of natural and reconstituted lipoprotein based nano drug delivery vehicles].
Xu Y; Jin XF; Ping QN; Liu HF; Chen M; Xu XM
Yao Xue Xue Bao; 2014 Jan; 49(1):23-9. PubMed ID: 24783501
[TBL] [Abstract][Full Text] [Related]
7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
8. Hydrogel-Based Drug Delivery Systems for Poorly Water-Soluble Drugs.
McKenzie M; Betts D; Suh A; Bui K; Kim LD; Cho H
Molecules; 2015 Nov; 20(11):20397-408. PubMed ID: 26580588
[TBL] [Abstract][Full Text] [Related]
9. Liposome-based drug delivery of various anticancer agents of synthetic and natural product origin: a patent overview.
Akhtar N; Mohammed SA; Singh V; Abdellatif AA; Mohammad HA; Ahad A; Yusuf M; Khadri H; Naz M; Khan O; Rashid M; Khan RA
Pharm Pat Anal; 2020 May; 9(3):87-116. PubMed ID: 32609057
[TBL] [Abstract][Full Text] [Related]
10. Nano-formulations of drugs: Recent developments, impact and challenges.
Jeevanandam J; Chan YS; Danquah MK
Biochimie; 2016; 128-129():99-112. PubMed ID: 27436182
[TBL] [Abstract][Full Text] [Related]
11. Natural low- and high-density lipoproteins as mighty bio-nanocarriers for anticancer drug delivery.
Mahmoudian M; Salatin S; Khosroushahi AY
Cancer Chemother Pharmacol; 2018 Sep; 82(3):371-382. PubMed ID: 29915981
[TBL] [Abstract][Full Text] [Related]
12. Patents in chemotherapy: nanoparticles as drug-delivery vehicles.
Talat A; Khan AU
Pharm Pat Anal; 2020 Jul; 9(4):117-119. PubMed ID: 32815487
[TBL] [Abstract][Full Text] [Related]
13. Cyclodextrin-Based Formulations: A Non-Invasive Platform for Targeted Drug Delivery.
Muankaew C; Loftsson T
Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):46-55. PubMed ID: 29024354
[TBL] [Abstract][Full Text] [Related]
14. Current Strategy for Cisplatin Delivery.
Yue Z; Cao Z
Curr Cancer Drug Targets; 2016; 16(6):480-8. PubMed ID: 27018267
[TBL] [Abstract][Full Text] [Related]
15. Filamentous supramolecular peptide-drug conjugates as highly efficient drug delivery vehicles.
Yang M; Xu D; Jiang L; Zhang L; Dustin D; Lund R; Liu L; Dong H
Chem Commun (Camb); 2014 May; 50(37):4827-30. PubMed ID: 24682213
[TBL] [Abstract][Full Text] [Related]
16. Recent Trends in Nanotechnology-Based Drugs and Formulations for Targeted Therapeutic Delivery.
Iqbal HMN; Rodriguez AMV; Khandia R; Munjal A; Dhama K
Recent Pat Inflamm Allergy Drug Discov; 2017; 10(2):86-93. PubMed ID: 27978790
[TBL] [Abstract][Full Text] [Related]
17. Amorphous drug delivery systems: molecular aspects, design, and performance.
Kaushal AM; Gupta P; Bansal AK
Crit Rev Ther Drug Carrier Syst; 2004; 21(3):133-93. PubMed ID: 15248808
[TBL] [Abstract][Full Text] [Related]
18. Loading anticancer drugs into HDL as well as LDL has little affect on properties of complexes and enhances cytotoxicity to human carcinoma cells.
Kader A; Pater A
J Control Release; 2002 Apr; 80(1-3):29-44. PubMed ID: 11943385
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein Drug Delivery Vehicles for Cancer: Rationale and Reason.
Chaudhary J; Bower J; Corbin IR
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847457
[TBL] [Abstract][Full Text] [Related]
20. Recent advances on patents in poly(ethylene glycol)-based drug delivery.
Bonora GM; Drioli S
Recent Pat Drug Deliv Formul; 2008; 2(2):189-95. PubMed ID: 19075907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
